{
    "2025-05-13": [
        {
            "title": "AMD Unveils EPYC 4005 Series Processors, Delivering Workload-Optimized Solutions for Entry-Level Enterprise",
            "description": "\u2014 AMD EPYC 4005 Processors provide a compelling balance of performance, dependability and efficiency in an affordable, easy-to-deploy platform \u2014 SANTA CLARA, Calif., May 13, 2025 (GLOBE NEWSWIRE) \u2014 AMD\u00a0(NASDAQ: AMD) today announced the\u00a0launch of AMD EPYC\u2122 400\u2026",
            "publishedAt": "2025-05-13",
            "source": "Financial Post",
            "url": "https://financialpost.com/globe-newswire/amd-unveils-epyc-4005-series-processors-delivering-workload-optimized-solutions-for-entry-level-enterprise"
        },
        {
            "title": "Vultr Deploys New AMD EPYC\u2122 4005 Series Processors to Deliver Easy-to-Use, Low-Cost Systems for Growing Businesses",
            "description": "Vultr delivers performance, dependability and efficiency in an affordable, easy-to-deploy platform with new AMD EPYC offerings WEST PALM BEACH, Fla. \u2014 Vultr, the world\u2019s largest privately-held cloud infrastructure company, today announced that it is one of th\u2026",
            "publishedAt": "2025-05-13",
            "source": "Financial Post",
            "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/vultr-deploys-new-amd-epyc-4005-series-processors-to-deliver-easy-to-use-low-cost-systems-for-growing-businesses"
        }
    ],
    "2025-05-07": [
        {
            "title": "AMD to Host Annual Meeting of Stockholders",
            "description": "SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) \u2014 AMD (NASDAQ: AMD) will hold its Annual Meeting of Stockholders on Wednesday, May 14, 2025 at 9 a.m. PDT as a virtual meeting accessible at Forward-looking and other material information may be discussed dur\u2026",
            "publishedAt": "2025-05-07",
            "source": "Financial Post",
            "url": "https://financialpost.com/globe-newswire/amd-to-host-annual-meeting-of-stockholders-2"
        }
    ],
    "2025-05-02": [
        {
            "title": "Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration",
            "description": "Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) \u2014 Chengdu Origen Biotechnology Co., Ltd. (\u201cChengdu Origen\u201d) and Vanotech Ltd. (\u2026",
            "publishedAt": "2025-05-02",
            "source": "Financial Post",
            "url": "https://financialpost.com/globe-newswire/chengdu-origen-and-vanotech-announce-first-patient-dosed-in-van-2401-phase-1-trial-of-gene-therapy-for-wet-age-related-macular-degeneration"
        }
    ]
}